Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis

Thrombosis Research

Volumn 132, Issue 5, 2013, Pages 515-519

  Piran, Siavash ^a   Le Gal, Grégoire ^a   Wells, Philip S ^a   Gandara, Esteban ^a   Righini, Marc ^b   Rodger, Marc A ^a   Carrier, Marc ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Major bleeding; Mortality; Outpatient management; Pulmonary embolism; VTE recurrence

Indexed keywords

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; FOLLOW UP; HUMAN; LUNG EMBOLISM; META ANALYSIS; MORTALITY; OUTPATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ACCP; AMERICAN COLLEGE OF CHEST PHYSICIANS; CI; CONFIDENCE INTERVAL; CT PULMONARY ANGIOGRAM; CTPA; DEEP VEIN THROMBUS; DVT; EBM; EVIDENCE BASED MEDICINE; ICH; INTRACRANIAL HEMORRHAGE; LMWH; LOW MOLECULAR WEIGHT HEPARIN; MAJOR BLEEDING; MORTALITY; N-TERMINAL PRO-HORMONE OF BRAIN NATRIURETIC PEPTIDE; NT-PROBNP; OUTPATIENT MANAGEMENT; PE; PESI; PULMONARY EMBOLISM; PULMONARY EMBOLISM SEVERITY INDEX; RANDOMIZED CONTROLLED TRIALS; RCTS; UFH; UNFRACTIONATED HEPARIN; V/Q; VENOUS THROMBOEMBOLISM; VENTILATION-PERFUSION; VTE; VTE RECURRENCE;

AMBULATORY CARE; HEMORRHAGE; HUMANS; OUTPATIENTS; PULMONARY EMBOLISM; RECURRENCE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84886096023     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.08.012     Document Type: Article

References (46)

1. M.N. Levine, M. Gent, J. Hirsh, J. LeClerc, D.R. Anderson, and J. Weitz A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis N Engl J Med 334 1996 677 681
2. E. Grau, J.M. Tenias, E. Real, J. Medranro, R. Ferrer, and E. Pastor Home treatment of deep venous thrombosis with low molecular weight heparin: long term incidence of recurrent venous thromboembolism Am J Hematol 67 2001 10 14
3. E. Ramacciotti, G.R. Araujo, S. Lastoria, F.H. Maffei, M. Karaogland, and W. Michaelis An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis Thromb Res 114 2004 149 153
4. M.M. Koopman, P. Prandoni, F. Piovella, P.A. Ockelford, D.P. Brandjes, and J. van der Meer Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group N Engl J Med 334 1996 682 687
5. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S
6. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, and P. Pruszczyk Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 2008 2276 2315
7. D. Aujesky, L. Mazzolai, O. Hugli, and A. Perrier Outpatient treatment of pulmonary embolism Swiss Med Wkly 139 2009 685 690
8. M.J. Agterof, R.E. Schutgens, R.J. Snijder, G. Epping, H.G. Peltenburg, and E.F. Posthuma Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level J Thromb Haemost 8 2010 1235 1241
9. P.M. Erkens, E. Gandara, P.S. Wells, A.Y. Shen, G. Bose, and G. Le Gal Safety of outpatient treatment in acute pulmonary embolism J Thromb Haemost 8 2010 2412 2417
10. M.J. Kovacs, J.D. Hawel, J.F. Rekman, and A. Lazo-Langner Ambulatory management of pulmonary embolism: a pragmatic evaluation J Thromb Haemost 8 2010 2406 2411
11. W. Zondag, I.C. Mos, D. Creemers-Schild, A.D. Hoogerbrugge, O.M. Dekkers, and J. Dolsma Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study J Thromb Haemost 9 2011 1500 1507
12. S. Siragusa, C. Arcara, A. Malato, R. Anastasio, M.R. Valerio, and F. Fulfaro Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients Ann Oncol 16 Suppl. 4 2005 iv136 iv139
13. C.G. Olsson, U. Bitzen, B. Olsson, P. Magnusson, M.S. Carlsson, and B. Jonson Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy Med Sci Monit 12 2 2006 PI9 PI13
14. M. Janjua, A. Badshah, F. Matta, L.G. Danescu, A.Y. Yaekoub, and P.D. Stein Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review Thromb Haemost 100 2008 756 761
15. A. Squizzato, M. Galli, F. Dentali, and W. Ageno Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review Eur Respir J 33 2009 1148 1155
16. R. Otero, F. Uresandi, D. Jimenez, M.A. Cabezudo, M. Oribe, and D. Nauffal Home treatment in pulmonary embolism Thromb Res 126 2010 e1 e5
17. D. Aujesky, P.M. Roy, F. Verschuren, M. Righini, J. Osterwalder, and M. Egloff Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open- label, randomised, non-inferiority trial Lancet 378 2011 41 48
18. D.R. Vinson, S. Zehtabchi, and D.M. Yealy Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review Ann Emerg Med 60 2012 651 662
19. W. Zondag, J. Kooiman, F. Klok, O. Dekkers, and M. Huisman Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis Eur Respir J 42 2013 134 144
20. C.J. van Dongen, A.G.M. van den Belt, M.H. Prins, and A.W.A. Lensing Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Cochrane Database Syst Rev 4 2004 1 69 10.1002/14651858 [Art.No.001100.CD001100.pub2]
21. H.R. Buller, A.T. Cohen, B. Davidson, H. Decousus, A.S. Gallus, and M. Gent Idraparinux versus standard therapy for venous thromboembolic disease N Engl J Med 357 2007 1094 1104
22. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
23. J.P.T. Higgins Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 Cochrane Database Syst Rev 2009
24. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Unpublished. 2009.
25. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
26. P.S. Wells, M.J. Kovacs, J. Bormanis, M.A. Forgie, D. Goudie, and B. Morrow Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight Heparin. A Comparison of patient self-injection with homecare injection Arch Intern Med 158 1998 1809 1812
27. A. Maestre, R. Sanchez, V. Rosa, D. Aujesky, A. Lorenzo, and G. Barillari Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: findings from the RIETE Registry Eur J Intern Med 21 2010 377 382
28. C. Kearon, J.S. Ginsberg, J.A. Julian, J. Douketis, S. Solymoss, and P. Ockelford Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism JAMA 296 2006 935 942
29. F. Conget, R. Otero, D. Jimenez, D. Marti, C. Escobar, and C. Rodriguez Short-term clinical outcome after acute symptomatic pulmonary embolism Thromb Haemost 100 2008 937 942
30. E.J. van Beek, P.M. Kuijer, H.R. Buller, D.P.M. Brandjes, P.M.M. Bossuyt, and J.W. ten Cate The clinical course of patients with suspected pulmonary embolism Arch Intern Med 157 1997 2593 2598
31. J.H. Beer, M. Burger, S. Gretener, S. Bernard-Bagattini, and H. Bounameaux Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients J Thromb Haemost 1 2003 18 186
32. C.W. Davies, J. Wimperis, E.S. Green, K. Pendry, J. Killen, and I. Mehdi Early discharge of patients with pulmonary embolism: a two-phase observational study Eur Respir J 30 2007 708 714
33. M. Rodríguez -Cerrillo, A. Alvarez-Arcaya, E. Fernandez-Diaz, and A. Fernandez-Cruz A prospective study of the management of non-massive pulmonary embolism in the home Eur J Intern Med 20 2009 598 600
34. M.J. Kovacs, D.R. Anderson, B. Morrow, L. Gray, D. Touchie, and P.S. Wells Outpatient treatment of pulmonary embolism with Dalteparin Thromb Haemost 83 2000 209 211
35. P.S. Wells, D.R. Anderson, M.A. Rodger, M.A. Forgie, P. Florack, and D. Touchie A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism Arch Intern Med 165 2005 733 738
36. M. Carrier, G. Le Gal, P.S. Wells, and M.A. Rodger Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism Ann Intern Med 152 2010 578 589
37. T. Baglin Fifty percent of patients with pulmonary embolism can be treated as outpatients J Thromb Haemost 8 2010 2404 2405
38. A. Ruppert, T. Steinle, and M. Lees Economic burden of venous thromboembolism: a systematic review J Med Econ 14 2011 65 74
39. B. Park, L. Messina, P. Dargon, W. Huang, R. Ciocca, and F.A. Anderson Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample Chest 2009 983 990
40. S. Shepperd, H. Doll, R.M. Angus, M.J. Clarke, S. Iliffe, and L. Kalra Admission avoidance hospital at home Cochrane Database Syst Rev 2008 CD007491
41. D.W. Bates, N. Spell, D.J. Cullen, E. Burdick, N. Laird, and L.A. Petersen The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group JAMA 277 1997 307 311
42. D. Aujesky, R. Hughes, and D. Jimenez Short-term prognosis of pulmonary embolism J Thromb Haemost 7 Suppl. 1 2009 318 321
43. A. Squizzato, M.P. Donadini, L. Galli, F. Dentali, D. Aujesky, and W. Ageno Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis J Thromb Haemost 10 2012 1276 1290
44. B.A. Hutten, M.H. Prins, M. Gent, J. Ginsberg, J.G. Tijssen, and H.R. Büller Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis J Clin Oncol 18 2000 3078 3083
45. C.J. van Dongen, M.R. Mac Gillavry, and M.H. Prins Once versus twice daily LMWH for the initial treatment of venous thromboembolism Cochrane Database Syst Rev 2003 CD003074
46. J.F. van der Heijden, B.A. Hutten, H.R. Buller, and M.H. Prins Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism Cochrane Database Syst Rev 2002 CD002001